Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Veterinary Medicine > Lymphoreticular system > Flashcards

Lymphoreticular system Flashcards

1
Q

Glucocorticoids

A

Associate with binding proteins - transcortin and albumin
Following dissociation from binding proteins, passively diffuse into cell
Bind to a cytoplasmic receptor (under 3)
Conformational change of receptor unmasks DNA binding domain; associates with GREs following nuclear translocation
Cellular targets:
-Inflammatory cells: eosinophil, T cell, Mast cell, Macrophages, dendritic cell
- Structural cells: epithelium, endothelium, airway smooth muscle, mucus glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glucocorticoid - potential adverse effects

A 
Central nervous systen - decreased mentation
Musculoskeletal system - muscle wasting
GIT
Fluid, electrolyte balance
Metabolic, endocrine
immune systems - secondary infections
Cats are more resistance that dogs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chlorambucil

A

Rapidly metabolised to phenylacetic acid mustard
Slowest acting, least toxic of all alkylating agents
Myelosuppression generally not observed until administered for > 1 month
Urinary and faecal excretion
Administered without food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Azathioprine

A

Greater decrease of cellular than humoral immunity
Hepatic metabolism to active 6-mercaptopurine then to 6-thioinosinic, 6-thioguanylic, thiouric acids
Compete with endogenous adenine and guanine -> non-functional nucleic acid strands
Slow immunosuppressive effect
Haematological, gastrointestinal, hepatic +/- neuromuscular toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vincristine, vinblastine

A

Bind to tubulin, blocking polymerisation
Also break down pre-formed microtubules - increased release of PLTs from megakaryocytes
Both used in rxl of ITP (usually vincristine)
Can be given as bolus IV or to preload PLTs
Severe extravascular vesicants
Haematological, GI, neurological toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ciclosporin

A

Isolated from Cylindrocarpon lucidium and Trichoderma polysporum
Both IV and oral forms
Large volume of distribution: primary hepatic metabolism
Therapeutic drug monitoring - acute and chronic
Ketoconazole may be used to reduce costs
GI, renal, hepatic toxicity; also hirsutism, gingivial hyperplasia, papillomatosis +/- diabetogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathogenesis of immune-mediated disease

A

Immune system overeacts to normal body tissues or harmless exogenous proteins - loss of tolerance
Both humoral and cellular mechanisms of tissue damage recognied
Loss of self-tolerance is necessary to perpetuate+/- start disease
Trigger factors:
- release of sequestered antigens
- abnormal immunoregulation
- molecular mimicry
- polyclonal activation of T and B cells
- exposure of cryptic epitopes or haptenisation of foreign molecules to self antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Role of infection in immune-mediated disease

A
  • Breakdown of vascular or cellular barriers allowing exposure of self antigens
  • Promotion of cell death by necrosis, causing inflammation -> bystander activation
  • Polyclonal activation of T cells - bacterial superantigens
  • Molecular mimicry -> cross reactivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aetiology of immune-mediated disease

A

Often unclear, likely to be multifactorial
- Genetic, infectious and hormonal influences
Canine examples:
- SLE: genetics (DLA-A7; C4-4), C-type viruses
- IMHA: vaccinal antigens?
- Immune-mediated polyarthritis: vaccinal antigens?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Signalment of immune-mediated disease

A

Idiopathic immune-mediated disease over-represented in juvenile to middle-aged patients, through dogs and cats of any age may be affected
Vet examples:
- SLE
- Dogs from 2 months - 13y (GSDs, shelties, collies, beagles, poodles)
- Cats from 1-11y (Siamese, Persian, Persian-related breeds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

History/physical exam of immune-mediated disease

A

Generally characterised by remission and exacerbation
Lameness, mucocutaneous lesions, lethargy, dyspnoea, weight loss, PU/PD, +/- seizures or behavioural changes
Effusive, painful joints, cutaneous erythema, macules, papules, pustules, erosion etc., pallor +/- petechiae, cardiac arrhythmias
Lymphadenomegaly +/- splenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnostic tests - CBC/coags

Immune-mediated disease

A

Anaemia - regenerative (IMHA) or non-regenerative (infection, uraemia, chronic bleeding, attack of precursors)
Thrombocytopaenia - Immune-mediated (I-M) thrombocytopaenia
Leucopaenia? anti-leucocytes antibodies e.g. SLE, I-M neutropaenia
Coagulation abnormalities: increase in APTT, PT,’anti-coagulant antibody’ (SLE), DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnostic tests - chemistry panel

Immune-mediated disease

A

Azotaemia, increased inorganic phosphate - chronic glomerular lesions
Hypoalbuminaemia, hypercholesterolaemia - protein-losing nephropathy (PLN)
Hyperbilirubinaemia - pre-hepatic/haemolysis
Hyperglobulinaemia - inflammatory disease, polyclonal B cell activation
Increased creatine kinase and lactate dehydrogenase - polymyositis and/or myocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diagnostic tests - urinalysis

Immune-mediated disease

A

Proteinuria:
- PLN: r/o UTI and occult infection(s) e.g. Dirofilaria immitis, Ehrlichia canis, Anaplasma phagocytophilum, Borrelia burgdorferi, Rickettsia rickettsiae, Bartonella spp.)
Haematuria, pyuria, erythrocyte casts:
- r/o UTI and occult infections
- compatible with membranoproliferative GN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnostic tests - radiography and arthrocentesis

A

Joint lesions are common in polysystemic IM disease, usually non-erosive pauciarthropathy
Erosive lesions suggest an overlap syndrome
Arthritis is not always clinically obvious
Synovial fluid: increased WBC, increased proportion of neutrophils +/- protein content with decreased viscosity and poor mucin clot formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Coomb’s test

Immune-mediated disease

A

If acute IMHA suspected, in-saline agglutination and osmotic fragility tests may be performed
Antibodies associated with the surface of RBCs may also be detected with the Coomb’s test
Primary reagent: polyvalent anti-dog or anti-cat IgG, IgM and C3 antiserum (direct antiglobulin test)
False positive and negative reactions may occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AChR autoantibodies

Immune-mediated disease

A 
Acquired MG (myasthenia gravis): most common of immune-mediated neuromuscular disorders
Various forms described: focal, generalised, acute fulminating, paraneoplastic
'Gold standard' for diagnosis of acquired MG is documentation of nicotinic AChR autoAb by immunoprecipitation RIA
False positives v rare; 2% of dogs with generalised MG may be seronegative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ANA - antinuclear antibodies

Immune-mediated disease

A

Serum ANA - hallmark of human, canine and feline SLE
Indirect immunofluorescence or immunoperoxidase test
Substrate tissues have inc. rat liver, vero and Hep-2 cells; various pattern of staining
False positives and negatives may occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Von Willebrand’s Factors (vWF)

A

Produced by endothelium and stored in Weibel Palade bodies
Also produced by platelets
Released early in the haemostatic process
Responsible for platelet adhesion to collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Platelets

A

Small discoid anuclear cells for in circulation
3-5 nanometres and are pale basophilic with small red granules
Derived from the cytoplasm of megakaryocytes in the bone marrow (thrombopoiesis)
Mediated by thrombopoietin
Circulate for 5-9 days in most species
Structure:
- Outer membrane contains receptors important for adhesion and aggregation
- Contain a cytoskeleton with actin and myosin that allows for shape change
- Contain membrane bound granules
Surface receptors:
- Glycoproteins associated with platelet membrane
- GP Ib - binds von Willebrand’s factor
- GP IIbIIa -binds fibrinogen on adjacent platelets and allows platelets to aggregate
- Defects in receptor lead to abnormal platelet function and clot formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Primary haemostasis

A

Damage to the endothelium and exposure of subendothelial collagen
Von Willebrand’s factor is released from damaged endothelium
Platelet adhesion occurs
Platelet bind to collagen via receptor GPIb and vWF from the endothelium
Once platelets have adhered to collagen, they undergo shape change and become spherical with filopodia
Additional receptors for vWF (GPIb) and fibrinogen (GPIIbIIa) are exposed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Secondary haemostasis

A

Involves activation of the coagulation cascade
Happens simultaneously with formation of the platelet plus because damage to the endothelium releases tissue factor and activates the extrinsic coagulation pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Coagulation cascade

Extrinsic system - intiation

A 
Most important in vivo
Tissue factor (TF) released from damaged tissue binds and activates FVII in presence of calcium
TF_FVII complex activates FX of the common pathway and FIX of the intrinsic pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Coagulation cascade

Intrinsic pathway - amplification

A

FXII is activated by contact with a negatively charged surface (cofactor HMWK)
Activated FXII cleaves and activates FXI which in turn activates FIX (calcium required)
Activated FIX i turn activates FX of the common pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Coagulation cascade

Common pathway

A

Starts with activation of Factor X
Activated FX binds activated Factor V and calcium on the platelet surface
This complex converts prothrombin (FII) to thrombin (FIIa)
Thrombin converts fibrinogen (FI) to fibrin (FIa)
Fibrin crosslinked by activated FXIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Inhibitors of coagulation

A

Anti-thrombin III - inhibits thrombin and activated FX
Activity of ATIII increased by heparin from the endothelium
Protein C - inactivates Factors V and VIII
Fibrinolysis (enzymatic breakdown of fibrin by plasmin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Immune-mediated thrombocytopaenia

A

Most common cause of thrombocytopaenia
Platelet numbers extremely low (often s syndome - concurrent immune mediated thrombocytopaenia and anaemia
Primary - antibodies produced against platelets antigens
Secondary - many causes (other immune diseases (SLE), drugs or vaccine, neoplasia, infectious)
Diagnosis of exclusion/response to treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Disorders of platelet function

A

Glanzmann’s thrombasthenia - defect in GPIIbIIIa
- Ottermans and Great Pyrenees, Quarter horse
- Defective platelet aggregation and abnormal clot retraction
Canine thrombopathia - abnormal GPIIbIIIa exposure and impaired degranulation - Basset hounds
Bovine thrombopathia - defect not know (Simmentals), mild to severe bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Thrombocytosis

A

Physiological - transient - epinephrine induced splenic contraction
Reactive (secondary)
- Increased thrombopoietin and possibly IL6
- Inflammation, haemorrhage, iron deficiency
Essential thrombocytemia
- Myeloproliferative disorder
- Marked peristent incerase in platelets
- Bone marrow megakaryocytes increased and may have abnormal morphology
- Function variable - may see petechiae and ecchymoses or thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Von Willebrand’s disease

A

Clinical signs: mucosal bleeding (GI, epistaxis, haematuria etc.)
Bleeding may be absent
No petechiae - use to differentiate from other platelet disorders
See prolonged buccal mucosal bleeding time without thrombocytopaenia
Clotting time usually normal but PTT msy be prolonged due to decrease in factor VIII]
Common in dogs (rare in cats and horses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Von Willebrand’s disease

Type I

A

All multimers are present but as decreased concentrations
Variable severity of bleeding but not until concentration of vWF are <20%
Most common - 90% cases
Dobermans
Autosomal inheritance so males and females equally affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Von Willebrand’s disease

Type II

A

Qualitative abnormalities in vWF structure and function
Often disproportionate decrease in large multimers
Severe and uncommon
Seen in German short haired and wire haired pointers
Autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Von Willebrand’s disease

Type III

A

Absence of all vWF multimers (<0.1%)
Seen in Scottish Terriers, Chesapeake Bay Retrievers, Shetland Sheepdogs and Dutch Kooiker
Autosomal recessive

34
Q

Von Willebrand’s disease

Tests

A

Measure levels of vWF:Ag

  • Collect blood into EDTA or citrate
  • If using citrate as anticoagulation - dilute blood:citrate at ratio of 1:9
  • vWF levels will be decreased by clots in the sample and by haemolysis but are inaffected by lipaemia
  • Separate plasma immmediately, freeze and ship overnight

ELISA: quantative measurement of vWF using specific antibodies -<50% considered decreased

Immunoelectrophoresis: used to separate relative amounts of different multimers - required for diagnosis of type II

Genetic test to detect carriers

35
Q

Von Willebrand’s disease

Treatment

A

Transfusion to supply vWF
Cryoprecipitate best - concentration of vWF 5-10x greater than in plasma - give at dose of 1 unit/10kg
Plasma can be given at 6-12 ml/kg if cryoprecipitate nto available
Whole blood if animal is anaemic
Desmopressin (DDAVP)as a pre-op prophylaxis for dogs with type I vWD
Causes release of vWF from endothelium
Give dose of 1 nanog/kg SQ 30 min prior to surgery
Intranasal preparation

36
Q

Vitamin K deficiency

A

Factors II, VII, IX and X are produced in the liver
Are activated by a vitamin K dependent carboxylase - this step requires reduced vitamin K
Production of reduced vitamin K requires the action of vitamin K reductase
Vitamin K reductase is inhibited by coumarin - type redenticides
This leads to a lack of active factors II, VII, IX and X and a coagulopathy
Extrinsic, intrinsic and common pathways affected
Factor VII has the shortest half life so will decrease 1st
PT is often prolonged 1st in early vitamin K deficency
Main clinical sign: haemorrhage
Test results: elevation in PT and PTT, platelet numbers and buccal mucosal bleeding time should be normal but mild thrombocytopaenia is possible - due to consumption associated with haemorrhage, FDP’s may also be elevated

37
Q

Vitamin K deficiency - Treatment

A

Emetics, cathartics, activated charcoal if ingestion of rodenticide is recent
Transfusions of whole fresh blood or fresh frozen plasma to replace coagulation factors
May also need packed red cells if severe anaemia is present
Vitamin K therapy:
- Can be given orally or parenterlly (SQ)
- Loading dose of SQ and then lower dose 8h later
- Same dose can be given orally with a fatty meal

38
Q

Inherited coagulation defects - treatment

Factor VII deficiency, Haemophilia A - factor VIII deficiency, Haemophilia B - factor IX deficiency, factor XI deficiency, Factor XII deficiency

A

Transfusions of whole blood or plasma to replace factor deficiency and red cells
Use of fresh or frozen plasma will give a small amount of factor
Administration of cryoprecipitate - 10x more factor VIII vs plasma

39
Q

Disseminated intravascular coagulation (DIC)

A

Mixed haemostatic defect
Results when excessive coagulation leads to widespread thrombosis
Haemorrhage eventually results as all coagulation factors are consumed
Not a primary event but secondary to other underlying disease (neoplasia, liver disease, immune mediated diseases, infectious diseases)
May be chronic or acute
Haemostatic abnormalities: thrombocytopaenia, prolonged PT and PTT, elevated FDP’s, decrease fibrinogen, decreased antithrombin III

40
Q

DIC - Treatment

A 
Stop the coagulation process
Heparin (different regimes)
Transfusion of whole blood, plasma or cryoprecipitate as source of antithrombin III
Aspirin to stop platelet activation
Correct other underlying abnormalities
Prognosis - poor
41
Q

FeLV

A

Family Retroviridae, subfamily Oncovirinae, genus Gammaretrovirus
Replicates in many tissues, non-cytopathic
Prevalence of 1-2% in ‘healthy’ cats in UK, 20% in symptomatic cats
Transmission: shed in saliva, nasal secretions, faeces, urine, milk, short survival outside of body
- Intimate prolonged contact
- Neonates (in utero, nursing)
- Blood transfusions
Persistent viraemia, transient viraemia, latent infection, localised infection

42
Q

FeLV

Clinical signs

A 
Inappetence
Weight loss, wasting
Poor coat condition
Lymphadenopathy
Persistent fever
Pale mm
Ocular disease
Gingivitis
Stomatitis
Infections of skin, urinary bladder, upper resp tract
Persistent diarrhoea
Seizures, behavioural changes and other neuro disorders
Queen's - abortions
43
Q

FeLV

Secondary infections

A

Immunosuppression - most common manifestation of FeLV
Depletion of interference with function of lymphocytes +/- neutrophils
Susceptible to co-infection - common for FeLV+ cats to have concurrent infection (opportunistic pathogens)

44
Q

FeLV

Haematological disorders

A

Bone marrow suppression: viral infection of haemopoietic stem cells and stromal cells
- Anaemia: non-regenerative, aplastic anaemia, regenerative (10%)
- Thrombocytopaenia
- Granulocytopaenia
Myelodysplasia -> myelodysplastic syndrome
Leukaemia (all cell lines susceptible)

45
Q

FeLV

Lymphoma

A

FeLV+ cats, >60x increased risk of lymphoma
Expect to develop in 25% of FeLV+ cats within two years of diagnosis
Most often mediastinal (thymic) and multicentric
Some cats with lymphoma test FeLV- but have virus in tumours

46
Q

FeLV

Diagnostic tests

A

Immunoassay - screening (ELISA)
Immunofluorescent antibody test (IFA) - confirms
Polymerase chain reaction (PCR) - confirms
Viral culture - gold standard confirms
Antibody tests - not for diagnosis

47
Q

FeLV

Treatment

A

Systemically well:

  • General preventative helath care
  • Neuter and confine indoors

Sick:

  • Supportive care
  • Treat secondary illness
  • Confine indoors
48
Q

FIV

A

Family Retroviridae, genus Lentivirus, RNA virus, five subtypes - similar to HIV, not zoonotic

Clinical findings: stomatitis, neoplasia, ocular inflammation (uveitis, chorioretinitis), anaemia and leucopaenia, opportunistic infections, renal insufficiency

49
Q

FIV

Diagnosis

A 
CBC: neutropaenia, anaemia common, thrombocytopaenia, co-infection with Mycoplasma haemofelis - haemolytic anaemia
Serum biochemical profile: no particular abnorm, +/- polyclonal gammapathy
Tests:
- Antibody test - develop with 60d
- IFA - detects antibodies
- Western blot - confirms
- PCR
- Viral isolation
50
Q

FIV

Treatment

A 
Supportive therapy:
- antibiotics (aerobes)
- cautious use of glucocorticoids in combo with antibiotics (gingivitis, stomatitis)
- lactoferrin - possibly in stomatitis
Antiviral therapy:
- Zidovudine
- Reduce plasma load
- Generally well tolerated but check for Heinz body haemolytic anaemia and non-regenerative anaemia
51
Q

FIV

Prevention of infection

A 
Prevent exposure to virus
Virus readily killed but disinfectants, dies within a few hours in environment
Low risk transmission by social contact
Do not breed fro FIV+ queens
If FIV+ queen, hand rear kittens
52
Q

FeLV

Subgroups

A

Subgroup A:
- present in almost all FeLV-infected cats
- transmitted cat-cat
- basis from production of other subgroup
- least pathogenic
Subgroup B:
- recombination of subgroup A with endogenous FeLV proviral sequences
- oncogenic
Subgroup C:
- arises from mutation of subgroup A
- non-regenerative anaemia

53
Q

FIP

A

Fatal disease, domestic and non-domestic cats
Causative agent: feline coronavirus, enveloped, ssRNA virus
Replicates in cytoplasm
FIP in 5-10% of FCoV infections
Vasculitis, complement activation, excessive cytokine formation
Clinical signs: consequences of vasculitis and secondary organ damage
Incubation period: weeks - months
Onset: sudden or insidious

54
Q

Feline enteric coronavirus (FECV)

A

Present in large portion of healthy cat population
Oronasal transmission
Virus replicates in enterocytes
Clinical signs mild/inapparent - V and D, upper resp signs

55
Q

Feline infectious peritonitis virus (FIPV)

A

FCoV may undergo mutations to FIPV
Infects macrophages -> systemic infection
FIP = clinical disease syndome result from ineffective immune reponse

56
Q

FIP

Clinical signs

A

Early:
- Pyrexia
- Inappetence/anorexia, weight loss
- Diarrhoea
- Listlessness, dehydration
- Jaundice (icterus)
Effusive vs non-effusive form (sometimes mixed)
- Effusive: abdominal, pleural, pericardial effusions
- Non-effusive: dry or granulomatous form, predisposition to eye, brain and CNS, kidney, liver, localised regions of intestine

57
Q

FIP

Diagnosis

A

Often difficult AM (esp dry form)

CBC: Lymphopaenia, neutrophilia with mild left shift, mild non-regenerative anaemia, may also be normal

Serum biochem: Hyperglbulinaemia (polyclonal increase in gamma globulins, albumin:globukin ratio <0.5) hyperbilirubinaemia, usually not azotaemic, may also be normal

Fluid analysis: clear, straw - yellow colour, high protein content, viscous, cellularity variable

58
Q

FIP

Treatment/prognosis

A

Grave prognosis - no cure usually, palliative treatment
Options:
- Suppotive/palliative care - Abx, SQ fluids, nutrition, rest, thoracocentesis
- Immune modulators
- Glucocorticoids +/- chlorambucil
- Aspirin?
- Oral polyprenyl immunostimulant

59
Q

FIA (feline infectious anaemia)

A

Haematropic mycoplasmas:
- Mycoplasma haemofelis: anaemia, pleiomorphic (rods, rings or spherical), gram negative, young entire males
- Candidatus Mycoplasma haemominutum:
- Candidatus Mycoplasms turicensis
Pathogenesis:
- Mycoplasmas attach to RBC -> immune-mediated destruction
- Concurrent diseases, immunosuppression -> enhanced disease
- If recover from infection -> chronic infection fro variable time

60
Q

FIA

Transmission

A

Fleas
Blood transfusion
Female cats to neonates - in utero, nursing
Fighting? Oral?
Experimentally: IP, IV and PO infected blood, urine and saliva not thought to be infective

61
Q

M. haemofelis

Clinical signs

A

Acute: lethargy, inappetence/anorexia, fever (39-41), anaemia, splenomegaly, icterus
Chronic: normal to subnormal temperature, weakness, depression, weight loss/emaciation, icterus and splenomegaly less likely

62
Q

M. haemofelis

CBC

A

Regenerative anaemia: varies in severity (PCV 15-18%), reticulocytosis, regenerative morphology, if acute onset may be pre-regenerative
Erythrophagocytosis and autoagglutination may be present
Leucocyte count variable:
- Leucocytosis with monocytosis in acute forms
- Normal counts in chronic forms
- Leucopaenia in moribund cases

63
Q

M. haemofelis

Treatment

A

Doxycycline: 5-10mg/kg orally bid for 14-21d
Potentially adverse effects: GIT effects, abdominal discomfort, vomiting, inappetence/anorexia, oesophagitis, oesopharyngeal stricture formation
Flea control
Supportive care: blood transfusion, immunosuppresive therapy (pred)

64
Q

M. haemofelis

Prognosis

A

No treatment - 1/3 with uncomplicated acute disease die

Regeneration - destruction + immune response to organism -> recovery

65
Q

Clinical signs of farm animal anaemia

A 
Pallor
Lack of exercise intolerance
Weakness
Haemic murmur
Red urine
Jaundice
Dependent oedema
Black faeces
Swollen udder
66
Q

Causes of haemorrhagic anaemia

Farm animals

A 
Caudal vena caval syndrome
Enzootic haematuria
Ruptured uterine artery
Ruptured aorta
Haemonchosis
Fasciolosis
Lice, mites and ticks
Pyelonephritis
Abomasal ulcer
Intraluminal intestinal haemorrhage
Gastric ulceration in pigs
Proliferative haemorrhagic enteropathy in pigs (PIA)
67
Q

Causes of haemolytic anaemic

Farm animals

A 
Leptospirosis
Postparturient haemoglobinuria
Bacillary haemoglobinuria
Protozoa (Babesia, Eperythrozoon)
Chronic copper poisoning
Cold water ingestion
Brassica spp poisoning (rape, kale, cabbages)
Drug induced
Blood transfusion
Autoimmune haemolytic anaemia
68
Q

Depressed erythrocyte production

Farm animals

A 
Deficiency of cobalt or copper
Iron deficiency
Acute bracken poisoning (enzootic haematuria)
Faciolosis
Lymphosarcoma
Chronic renal disease (amyloidosis, pyelonephritis)
Anaemia of inflammatory disease
Radiation damage
69
Q

Enzootic haematuria

A

Clinical signs:
- Haematuria with blood clots
- Freq urination
- Thickened bladder may or may not be palpable per rectum
- Other signs of chronic progressive anaemia
- Internal bleedings
Diagnosis:
- Most common cause of haematuria in cattle
- Pyelonephritis also causes haematuria but not necessarily anaemia

70
Q

Abomasal ulcer

A 
Sand, DA, 'stress'
Diagnosis:
- Occult blood in faeces/black stinking dung
- Free air in the abdomen
- Abdominal pain
71
Q

Chronic copper poisoning

Farm animals

A

Species and breed variation in susceptibility
Copper is stored and accumulated in the liver
Some centrilobular necrosis occurs as liver copper concentrations rise
Sudden release of copper from the liver - acute fatal syndrome develops

72
Q

Chronic copper poisoning

Farm animals - Diagnosis

A

Clinical signs: jaundice, pallor, haemoglobinuria, depression, death (24-48h)
Clinical path: Blood copper elevated, liver copper elevated, increased plasma AST
Necopsy: swollen yellow liver, swollen gunmetal kidneys, jaundice everywhere

73
Q

Chronic copper poisoning

Farm animals - Treatment

A

Treatment:

  • Ammonium tetrathiomolybdate (ATM) 2.7 mg/kg IV 2-3d intervals 3-6 treatments
  • Ammonium molybdate 100mg + sodium aulphate 1g oral daily
  • Sodium calcium edetate 70mg/kg IV 2d
  • Somnulose 10ml IV
74
Q

Chronic copper poisoning

Farm animals - prevention

A

Dietary copper < 10 ppm
Cu absorption inhibitors (Mo, Zn, Fe and soil)
Avoid prolonged feeding of concentrates

75
Q

Physiology of colostrum - calves

A

Starting 4-6 weeks before calving there is transfer of immunoglobulins (Ig) into the udder
IgG1 is actively transferred into colostrum
Following ingestion of colostrum by the calf, Ig is absorbed by the epithelial cells of the SI and passes via the lymphatic system to the peripheral blood circulation
Systemic production in the calf by IgG and IgM

Local protection of intestine by:

  1. re-secretion of IgG into the gut lumen
  2. passage of IgA in colostrum (and milk) through the gut lumen
76
Q

Immune mediated haemolytic anaemia - Eqine

A

Primary - uncommon
Secondary - antibodies attach to RBC membranes:
- Alterations in RBC membrane produced by primary infectious, neoplastic or other immune-mediated disease process
- Antigen-antibody complex deposition on RBC surface
- Drugs that cause immunoproteins to react indirectly with RBCs

77
Q

Oxidative damage to RBCs (Heinz body anaemia)

Equine

A

Heinz bodies are precipitations of oxidatively denatured haemoglobin on RBC membrane
Can be caused by rarely used drugs (methylen blue, phenothiazine) or plants (onions, Brassica spp: rape, kale)
Exception: red maple leaf toxicity

78
Q

Equine infectious anaemia

A

Exotic, Equine infectious anaemia virus (lentivirus)

Persistent infection: no treatment, lifelong carriers

79
Q

Anaemia of chronic disease

Equine

A 
Most common cause
Mild-moderatre regenerative anaemia
Pathogenesis:
- Iron sequestration - anti-bacterial mechanism
- Defective erythropoietin
- Decreased RBC lifespan
80
Q

Failure of passive transfer - foal

A

Lack of colostrum/poor quality
Failure to nurse
Failure of absorption
Measure IgG conc - <12-18h oral colostrum unless foal has system disease process
- or IV plasma - 1l = 2g in blood (2l usually required)
- Repeat measuring/transfusions as necessary

81
Q

Neonatal isoerythrolysis - foals

A

Destruction of foal’s RBC by antibodies present in colostrums directed against foal’s RBC antigens
Blood group incompatibility between mare and foal
Clinical signs:
- First 4d of life
- Weakness, lethargy, increased hr and rr, icterus, pale mm
Diagnosis on clinical signs and haemolytic cross match
Treatment:
- 24-48 hours - prevent further colostrum intake
- Over that, supportive care
- Blood transfusion: mare’s washed red cells (not plasma) or typed donor

82
Q

Sever combined immunodeficiency - horses

A

Arab foals - autosomal recessive inheritance
Lack of functional T and B lymphocytes
Fatal by several months of age
Can test for SCID gene

Veterinary Medicine (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions